Correction: Repurchase of shares in AstraZeneca PLC

CORRECTION REPURCHASE OF SHARES IN ASTRAZENECA PLC AstraZeneca PLC announces that on 25 February 2000, it purchased for cancellation 500,000 ordinary shares of AstraZeneca PLC at a price of 2026 pence per share. G H R Musker Company Secretary 28 February 2000 ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/02/28/20000228BIT00190/bit0001.doc http://www.bit.se/bitonline/2000/02/28/20000228BIT00190/bit0002.pdf

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe